Jonathan Mow

Verkställande Direktör på PHASEBIO PHARMACEUTICALS, INC.

61 år

Health Technology

Consumer Services

Profil

Jonathan P.
Mow was the founder of Corus Pharma, Inc., established in 2001, where the titles held included Secretary & VP-Commercial & Business Development from 2001 to 2006.
Current jobs include Chief Executive Officer & Director at PhaseBio Pharmaceuticals, Inc. since 2014, and Chief Executive Officer & Director at Veralox Therapeutics, Inc. since 2023.
Former jobs include Chief Executive Officer at Trefoil Therapeutics, Inc., Director-Worldwide Oncology Marketing at Bristol Myers Squibb Co. from 1995 to 1997, Vice President-Business Development at Amylin Pharmaceuticals, Inc. from 2007 to 2012, and Principal roles at PathoGenesis Corp, Syntex Laboratories, Inc., and Lederle International.
Education history includes undergraduate studies at the University of California, Berkeley, and an MBA from Tepper School of Business.

Aktiva positioner av Jonathan Mow

Företag	Position	Start
PHASEBIO PHARMACEUTICALS, INC.	Verkställande Direktör	2014-09-01
Veralox Therapeutics, Inc. Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides drug discovery and development services for clinical stage company	Verkställande Direktör	2023-06-20

Alla aktiva positioner av Jonathan Mow

Tidigare kända positioner av Jonathan Mow

Företag	Position	Slut
Amylin Pharmaceuticals, Inc. Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases	Företagsledare/Principal	-
Corus Pharma, Inc. Corus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat needs in the infectious diseases and respiratory areas	Grundare	2006-01-01
BRISTOL-MYERS SQUIBB COMPANY	Företagsledare/Principal	1997-01-01
Trefoil Therapeutics, Inc. Trefoil Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company which focuses on the application of novel engineered FGF-1 compounds to treat corneal diseases	Verkställande Direktör	-
Syntex Laboratories, Inc.	Företagsledare/Principal	-

Se detaljerna i Jonathan Mows erfarenhet

Jonathan Mows utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Jonathan Mows erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	11
Amylin Pharmaceuticals, Inc. Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases	Health Technology
Bristol Myers Squibb Co. Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products	Health Technology
PathoGenesis Corp PathoGenesis Corp BiotechnologyHealth Technology Develops and markets innovative treatments for chronic infectious diseases	Health Technology
Corus Pharma, Inc. Corus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat needs in the infectious diseases and respiratory areas	Health Technology
PhaseBio Pharmaceuticals, Inc. PhaseBio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of novel therapies for cardiovascular diseases	Health Technology
University of California, Berkeley University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Syntex Laboratories, Inc.
Lederle International
Tepper School of Business Tepper School of Business Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Trefoil Therapeutics, Inc. Trefoil Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company which focuses on the application of novel engineered FGF-1 compounds to treat corneal diseases	Health Technology
Veralox Therapeutics, Inc. Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides drug discovery and development services for clinical stage company	Health Technology